AbbVie

Traded on the St. Petersburg Stock Exchange

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. AbbVie develops drugs and treatments for patients with age-related diseases, including neurodegeneration and various forms of cancer. The company employs around 30,000 people worldwide.

P/E adj.

Net profit (adj.)

P/B

Book value

P/FCF

FCF

Yield

Growth potential

Report period	2018	2019	2020	2021	2022	2023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Report period	2018	2019	2020	2021	2022	2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Report period	2018	2019	2020	2021	2022	2023
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Report period	2018	2019	2020	2021	2022	2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin

Ticker	Name	Type	Nominal value	ISIN	Price
ABBV:US	AbbVie Inc.	Common share	-	US00287Y1091	$210.8

AbbVie news

27.10.2023

AbbVie Board of Directors announced a quarterly dividend of $1.55 per share. The last day to buy securities to receive the dividend is January 12, 2024. The annual dividend yield may reach 5.17%.

Source:

news.abbvie.com

27.10.2023

AbbVie's GAAP net income for 9 months of 2023 totaled $4.049 billion, down 2.3 times from $9.373 billion in the previous year. Revenue fell 6.8% to $40.017 billion from $42.933 billion a year earlier.

Source:

news.abbvie.com

11.09.2023

The AbbVie Board of Directors announced a quarterly dividend of $1.48 per share. The last day to buy securities to receive the dividend is October 11, 2023. The annual dividend yield may reach 5.04%.

Source:

news.abbvie.com

27.07.2023

AbbVie's GAAP net income for 6 months of 2023 totaled $2.268 billion, down 2.4 times from $5.421 billion in the previous year. Revenue declined 7.2% to $26.09 billion from $28.121 billion a year earlier.

Source:

investors.abbvie.com

All AbbVie news

General information

Company name	AbbVie
Tags	#pharmacy, #dividend aristocrats, #s&p500 index
Sector	Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address	1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
Mailing address	1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Website	investors.abbvie.com
Information disclosure	www.sec.gov

AbbVie

AbbVie balance sheet

AbbVie cash flows

AbbVie multipliers

AbbVie profitability

AbbVie shares